 - Failure to respond adequately to at least two antidepressant medication trials and two augmentation strategies. One augmentation strategy may include a noradrenergic dose of venlafaxine 225 mgday or duloxetine 120 mgday, given their dual mechanism of action99,100 and a 12-week cognitive behavioural or interpersonal therapy 